Literature DB >> 6615049

Surgical results and protocols in the spectrum of tetralogy of Fallot.

J W Kirklin, E H Blackstone, J K Kirklin, A D Pacifico, J Aramendi, L M Bargeron.   

Abstract

Between 1967 and July 1982, 1103 operations were performed for the tetralogy of Fallot of all types with 116 (10.5%) hospital deaths. Eighty-eight hospital deaths (10.5%) occurred in the 836 patients undergoing repair. The incremental risk factors for hospital death after repair include pulmonary arterial problems (p = 0.0002), major associated cardiac anomalies (p less than 0.0001), small size (young age) (p less than 0.0001), and more than one previous operation (p = 0.0004). Absent pulmonary valve is a risk factor (p = 0.04). In patients with pulmonary stenosis, the hospital mortality has decreased with time (p = 0.08), but the incremental risk of a high hematocrit (p = 0.0003) and of transannular patching (p = 0.05) has persisted. In the current era, the risk of repair in patients with pulmonary stenosis is estimated to be 1.6% (70% confidence limits [CL] 0.7% to 3.5%) at age 5 years, and at age 12 months to be 4.1% (CL 2.7% to 6.3%) without a transannular patch and 7.7% (CL a5.3% to 11%) with one. When pulmonary atresia is present, the probability of hospital death after repair when a valved extracardiac conduit is used is estimated to be lowest (5%; CL 2% to 8%) between 5 1/2 and 16 years of age. No deaths occurred among 53 patients with pulmonary stenosis receiving a primary palliative Blalock-Taussig or Gore-Tex shunt, and six deaths (12%) occurred in 51 patients with pulmonary atresia. Serious interim complications (sudden death, brain abscess) after these shunts occurred in two (1.9%; CL 0.6% to 4.5%) of the patients operated on. No iatrogenic pulmonary arterial problems have been recognized. Protocols based on these results are presented. Many of these selective recommendations may become unnecessary if the damaging effects of cardiopulmonary bypass are overcome by future research.

Entities:  

Mesh:

Year:  1983        PMID: 6615049      PMCID: PMC1353289          DOI: 10.1097/00000658-198309000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  Subclavian arterioplasty for the ipsilateral Blalock-Taussig shunt.

Authors:  H Laks; A R Castaneda
Journal:  Ann Thorac Surg       Date:  1975-03       Impact factor: 4.330

2.  Prolonged safe aortic clamping by combining membrane stabilization, multidose cardioplegia, and appropriate pH reperfusion.

Authors:  D Follette; K Fey; D Mulder; J V Maloney; G D Buckberg
Journal:  J Thorac Cardiovasc Surg       Date:  1977-11       Impact factor: 5.209

3.  Surgical management of pulmonary stenosis in tetralogy of Fallot.

Authors:  A D Pacifico; J W Kirklin; E H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  1977-09       Impact factor: 5.209

4.  Repair of tetralogy of Fallot in infancy. Early and late results.

Authors:  A R Castaneda; M D Freed; R G Williams; W I Norwood
Journal:  J Thorac Cardiovasc Surg       Date:  1977-09       Impact factor: 5.209

5.  Coronary perfusion versus cold ischemic arrest during aortic valve surgery. A randomized study.

Authors:  R N Sapsford; E H Blackstone; J W Kirklin; R B Karp; N T Kouchoukos; A D Pacifico; C R Roe; E L Bradley
Journal:  Circulation       Date:  1974-06       Impact factor: 29.690

6.  Cold cardioplegia versus hypothermia for myocardial protection. Randomized clinical study.

Authors:  V R Conti; E G Bertranou; E H Blackstone; J W Kirklin; S B Digerness
Journal:  J Thorac Cardiovasc Surg       Date:  1978-11       Impact factor: 5.209

7.  Transatrial repair of tetralogy of Fallot.

Authors:  L H Edmunds; N C Saxena; S Friedman; W J Rashkind; P F Dodd
Journal:  Surgery       Date:  1976-12       Impact factor: 3.982

8.  Selective operative treatment for tetraology of Fallot: rationale and results.

Authors:  H W Bender; R D Fisher; D M Conkle; C E Martin; T P Graham
Journal:  Ann Surg       Date:  1976-06       Impact factor: 12.969

9.  Routine primary repair vs two-stage repair of tetralogy of Fallot.

Authors:  J W Kirklin; E H Blackstone; A D Pacifico; R N Brown; L M Bargeron
Journal:  Circulation       Date:  1979-08       Impact factor: 29.690

10.  Tetralogy of Fallot with subpulmonary ventricular septal defect.

Authors:  R Neirotti; E Galindez; G Kreutzer; A Rodriguez Coronel; M Pedrini; L Becu
Journal:  Ann Thorac Surg       Date:  1978-01       Impact factor: 4.330

View more
  9 in total

1.  Percutaneous transcatheter myectomy of subvalvar pulmonary stenosis in tetralogy of Fallot: a new palliative technique with an atherectomy catheter.

Authors:  S A Qureshi; J M Parsons; M Tynan
Journal:  Br Heart J       Date:  1990-08

2.  Complete repair of tetralogy of Fallot in the neonate: results in the modern era.

Authors:  J C Hirsch; R S Mosca; E L Bove
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 3.  Complete Repair of Tetralogy of Fallot in the Neonatal Versus Non-neonatal Period: A Meta-analysis.

Authors:  Rohit S Loomba; Matthew W Buelow; Ronald K Woods
Journal:  Pediatr Cardiol       Date:  2017-02-11       Impact factor: 1.655

4.  Tetralogy of Fallot.

Authors:  Samantha C. Gouw; Thuy-Nga Le; Narayanswami Sreeram
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10

5.  Short-term clinical and echocardiographic outcomes after use of polytetrafluoroethylene bicuspid pulmonary valve during the repair of tetralogy of Fallot.

Authors:  Prashant Ramdas Wankhade; Neeraj Aggarwal; Reena Khantwal Joshi; Mridul Agarwal; Raja Joshi; Ashwani Mehta; Sibashankar Kar
Journal:  Ann Pediatr Cardiol       Date:  2019 Jan-Apr

Review 6.  Blue babies: when to intervene.

Authors:  Savitri Shrivastava
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

Review 7.  Timing of surgery/catheter intervention in common congenital cardiac defects.

Authors:  S Shrivastava
Journal:  Indian J Pediatr       Date:  2000-04       Impact factor: 1.967

8.  The utility of preoperative level of erythrocytosis in the prediction of postoperative blood loss and 30-day mortality in patients with tetralogy of fallot.

Authors:  Jhon Harold Guevara; Andres Zorrilla-Vaca; Gloria C Silva-Gordillo
Journal:  Ann Card Anaesth       Date:  2017 Apr-Jun

9.  Tetralogy of Fallot: morphological variations and implications for surgical repair.

Authors:  Saad M Khan; Nigel E Drury; John Stickley; David J Barron; William J Brawn; Timothy J Jones; Robert H Anderson; Adrian Crucean
Journal:  Eur J Cardiothorac Surg       Date:  2019-07-01       Impact factor: 4.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.